Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Ind Health ; 36(8): 558-566, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32869731

ABSTRACT

Occupational exposure in spraying and application of non-arsenical insecticides has been classified as a probable human carcinogen. The fundamental molecular mechanisms involved the tumor-related genes. This study aimed to investigate the carcinogenesis effects related to chronic exposure to organophosphate (OP) pesticides in pesticide applicators. This was a cross-sectional study conducted on 27 pesticide applicators and 24 matched controls through the period from June to December 2018. The level of acetylcholinesterase (AChE) was determined and the effects of OPs exposure on messenger RNA (mRNA) expression of the DNA-damage responsive genes P53, P21, GADD45a, and MDM2 were determined using real-time quantitative polymerase chain reaction. A significant reduction of serum AChE enzyme activities was observed in chronically exposed subjects in comparison with the control group (p = 0.001). The expression of P53, P21 mRNA was significantly downregulated in the exposed group compared with the healthy nonexposed control group (p < 0.05). Conversely, the expression of MDM2 and GADD45a did not significantly differ between the exposed subjects and the control group (p > 0.05). No significant differences were noted between the exposed and control groups regarding the genotype or allele distributions of P53 Arg72Pro polymorphism. These results suggested that chronic exposure to OP insecticides may have mitogenic and carcinogenicity activity for the exposed cases due to downregulation of P53 and P21 but did not demonstrate any DNA damage properties for the exposed cases, and finally, a regular follow-up of the exposed cases for tumor markers is recommended.


Subject(s)
Biomarkers, Tumor/genetics , DNA Damage/genetics , Genes, Tumor Suppressor/drug effects , Genes, p53/genetics , Occupational Exposure/adverse effects , Organophosphorus Compounds/adverse effects , Acetylcholinesterase/blood , Adolescent , Adult , Biomarkers, Tumor/analysis , Cell Cycle Proteins/genetics , Cross-Sectional Studies , Egypt , Genotype , Humans , Insecticides , Male , Middle Aged , Mitochondrial Proteins/genetics , Peptide Elongation Factor Tu/genetics , Pesticides , Proto-Oncogene Proteins c-mdm2/genetics , RNA, Messenger , Young Adult
2.
J Occup Health ; 60(2): 182-191, 2018 Mar 27.
Article in English | MEDLINE | ID: mdl-29311439

ABSTRACT

BACKGROUND: Work stress among nurses has increased in recent years due to the demands of clinical nursing. OBJECTIVES: To investigate psychosocial work stress among nurses using the effort-reward imbalance (ERI) model with assessment malondialdehyde (MDA) as an oxidative stress marker and total antioxidants. METHODS: The present study was conducted on 204 registered nurses worked at two tertiary hospitals in Menoufia governorate, Egypt through the period from the 1st of February to the end of July 2016. Two questionnaires were applied including general demographic and occupational histories as well as effort-reward questionnaire. Blood analysis was performed to assess MDA and total antioxidant levels. RESULTS: ERI was prevalent among the study participants (72.5%). ERI was more prevalent among young married nurses who worked more than 10 years. Nurses that worked at ICUs complained more of ERI (43.2%) while nurses that worked at operation rooms complained more of overcommitment (62.5%). MDA levels were significantly positively correlated with E/R ratios (rho = 0.350, P ≤ 0.001). CONCLUSIONS: Work stress was prevalent among the studied nurses as revealed by the high ERI and MDA levels. Young married female nurses complained more of work stress. ICUs and operating rooms were the most stressful departments at the studied hospitals. Hence, implementing programs and strategies that eliminate stressful working conditions at hospitals is critical to the reduction and prevention of work stress among nurses.


Subject(s)
Malondialdehyde/blood , Nursing Staff, Hospital/psychology , Occupational Stress/blood , Occupational Stress/epidemiology , Oxidative Stress/physiology , Workplace/psychology , Adult , Cross-Sectional Studies , Drugs, Chinese Herbal , Eleutherococcus , Female , Hospital Departments , Humans , Male , Middle Aged , Models, Psychological , Reward , Socioeconomic Factors , Young Adult
3.
Clin Lab ; 62(10): 1879-1885, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-28164540

ABSTRACT

BACKGROUND: Hepatitis C virus (HCV) is a major health problem worldwide particularly in Egypt. The humoral immune response has an important function in the control of HCV infection. The aim of this study was to investigate the role of neutralizing antibodies in Hepatitis C Virus (HCV) clearance in infected individuals. METHODS: This study was carried out on apparently healthy blood donors (n = 200). Detectable HCV antibodies were assessed by commercial ELISA and specific human immunoglobulins targeting peptides derived from HCV E1/E2 glycoproteins were measured in donors' blood using an in house optimized ELISA. Human IgG purification was carried out from positive HCV RNA and negative HCV RNA samples in order to evaluate its neutralizing activity in vitro using Huh 7 cells. RESULTS: The studied cohort included 96/200 subjects who tested positive for HCV antibodies, among which 56/96 (58%) samples were positive for HCV RNA (Group 1) and 40/96 (42%) samples had undetectable HCV RNA (Group 2). ELISA results showed that Human HCV immunoglobulin (HHI) targeting HCV E1 synthetic peptide (a.a. 315 - 323) was detectable in 63/96 (66%) and HHI targeting HCV E2 (a.a. 412 - 419) tested positive in 14/96 (15%) while 19/96 (20%) were positive for HCV E2 (a.a. 517 - 531). HHI higher than the cutoff level against peptide HCV E1 (a.a. 315 - 323) was detected in 22/63 (35%) in Group 2 and positive in 41/63 (65%) in Group 1. HHI against peptide HCV E2 (a.a. 412 - 419) was positive in 7 (50%) blood donors in Group 2 and also positive in 7 (50%) of Group 1. While HHI targeting HCV E2 (a.a. 517 - 531) was positive in 11 (60%) in Group 2 compared with 8 cases (40%) in Group 1. Purified human antibodies from cases positive for HCV antibodies and negative for HCV RNA showed in vitro neutralization at concentrations 30 and 10 µg/mL while the same concentration of purified human IgG from cases positive for HCV RNA showed no viral neutralization. CONCLUSIONS: The tested epitope(s) derived from HCV envelope E1 and E2 are important for viral clearance and hence can be used for HCV vaccine development.


Subject(s)
Blood Donors , Hepatitis C Antibodies/blood , Viral Envelope Proteins/immunology , Viremia/virology , Adult , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/blood , Middle Aged , RNA, Viral/blood , Viral Hepatitis Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...